mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0077 |
0.8 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.0074 |
0.8 |
mRNA |
CI-976 |
CTRPv2 |
pan-cancer |
AAC |
0.0084 |
0.8 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0075 |
0.8 |
mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
0.0098 |
0.8 |
mRNA |
Cisplatin |
GDSC1000 |
pan-cancer |
AAC |
0.0073 |
0.8 |
mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
-0.0079 |
0.8 |
mRNA |
L-685458 |
CTRPv2 |
pan-cancer |
AAC |
0.0078 |
0.8 |
mRNA |
BEC |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.8 |